COGEVIS: A New Scale to Evaluate Cognition in Patients with Visual Deficiency

Behavioural Neurology, IOS Press, 2018, 2018, pp.1-7 We evaluated the cognitive status of visually impaired patients referred to low vision rehabilitation (LVR) based on a standard cognitive battery and a new evaluation tool, named the COGEVIS, which can be used to assess patients with severe visual...

Full description

Saved in:
Bibliographic Details
Main Authors: Meyniel, Claire, Samri, Dalila, Stefano, Farah, Crevoisier, Joel, Bonté, Florence, Migliaccio, Raffaella, Delaby, Laure, Bertrand, Anne, Habert, Marie Odile, Dubois, Bruno, Bodaghi, Bahram, Epelbaum, Stéphane
Format: Journal Article
Language:English
Published: 18-12-2018
Subjects:
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Behavioural Neurology, IOS Press, 2018, 2018, pp.1-7 We evaluated the cognitive status of visually impaired patients referred to low vision rehabilitation (LVR) based on a standard cognitive battery and a new evaluation tool, named the COGEVIS, which can be used to assess patients with severe visual deficits. We studied patients aged 60 and above, referred to the LVR Hospital in Paris. Neurological and cognitive evaluations were performed in an expert memory center. Thirty-eight individuals, 17 women and 21 men with a mean age of 70.3 $\pm$ 1.3 years and a mean visual acuity of 0.12 $\pm$ 0.02, were recruited over a one-year period. Sixty-three percent of participants had normal cognitive status. Cognitive impairment was diagnosed in 37.5% of participants. The COGEVIS score cutoff point to screen for cognitive impairment was 24 (maximum score of 30) with a sensitivity of 66.7% and a specificity of 95%. Evaluation following 4 months of visual rehabilitation showed an improvement of Instrumental Activities of Daily Living (p = 0 004), National Eye Institute Visual Functioning Questionnaire (p = 0 035), and Montgomery-{\AA}sberg Depression Rating Scale (p = 0 037). This study introduces a new short test to screen for cognitive impairment in visually impaired patients.
DOI:10.48550/arxiv.1812.07328